-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Starling Oncology, Raises Price Target to $10

Benzinga·11/06/2026 10:37:10
Listen to the news
BTIG analyst David Larsen maintains Starling Oncology (NASDAQ:STLN) with a Buy and raises the price target from $9 to $10.